JP2006045157A - 養毛剤 - Google Patents
養毛剤 Download PDFInfo
- Publication number
- JP2006045157A JP2006045157A JP2004230808A JP2004230808A JP2006045157A JP 2006045157 A JP2006045157 A JP 2006045157A JP 2004230808 A JP2004230808 A JP 2004230808A JP 2004230808 A JP2004230808 A JP 2004230808A JP 2006045157 A JP2006045157 A JP 2006045157A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- hair
- kobatei
- kusunohagashi
- nourishing agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004209 hair Anatomy 0.000 title claims abstract description 44
- 230000001256 tonic effect Effects 0.000 title abstract 3
- 239000004480 active ingredient Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 19
- 239000004615 ingredient Substances 0.000 abstract description 5
- 240000003450 Mallotus philippensis Species 0.000 abstract description 4
- 235000018639 Terminalia sericea Nutrition 0.000 abstract description 4
- 241000844454 Terminalia sericea Species 0.000 abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 30
- 239000003795 chemical substances by application Substances 0.000 description 22
- 239000002609 medium Substances 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 13
- 230000003779 hair growth Effects 0.000 description 13
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 12
- 235000019441 ethanol Nutrition 0.000 description 12
- 201000004384 Alopecia Diseases 0.000 description 11
- 229920002683 Glycosaminoglycan Polymers 0.000 description 10
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 9
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 9
- 230000003676 hair loss Effects 0.000 description 9
- 208000024963 hair loss Diseases 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical group C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000002904 solvent Substances 0.000 description 7
- 238000009472 formulation Methods 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 4
- 238000013329 compounding Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 230000023750 transforming growth factor beta production Effects 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 210000003780 hair follicle Anatomy 0.000 description 3
- 230000003660 hair regeneration Effects 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 210000004761 scalp Anatomy 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical class C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 206010040954 Skin wrinkling Diseases 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 231100000360 alopecia Toxicity 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229950004580 benzyl nicotinate Drugs 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 229960005309 estradiol Drugs 0.000 description 2
- 229930182833 estradiol Natural products 0.000 description 2
- 239000012894 fetal calf serum Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000003405 preventing effect Effects 0.000 description 2
- 230000003658 preventing hair loss Effects 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 208000003024 Diffuse alopecia Diseases 0.000 description 1
- 241000221017 Euphorbiaceae Species 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000007547 Laminin Human genes 0.000 description 1
- 108010085895 Laminin Proteins 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical class CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- JZKFHQMONDVVNF-UHFFFAOYSA-N dodecyl sulfate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCOS(O)(=O)=O JZKFHQMONDVVNF-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 230000003659 hair regrowth Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 229940125697 hormonal agent Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000004037 social stress Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
【解決手段】 養毛剤にクスノハガシワ抽出物又はコバテイシ抽出物の少なくともいずれかを有効成分として含有させたことを特徴とする。
【選択図】 なし
Description
(実施例1)
本実施例の養毛剤は、クスノハガシワ(Mallotus philippinensis Mueller-Argoviensis)の樹皮の抽出成分からなるものである。その1つの製造例について説明すると、クスノハガシワ(Mallotus philippinensis Mueller-Argoviensis)の樹皮(乾燥物)200gを2L の50%エタノールに浸漬し、60〜80℃で2日間抽出し、抽出液から溶媒を除去し、5.3gの抽出物を得た。
本実施例の養毛剤は、コバテイシ(Terminalia sericea Bunch. L)の根の抽出成分からなるものである。その1つの製造例について説明すると、コバテイシ(Terminalia sericea Bunch. L)の根(乾燥物)200gを2L の50%エタノールに浸漬し、60〜80℃で2日間抽出し、抽出液から溶媒を除去し、9.5gの抽出物を得た。
ヒト毛乳頭細胞を12wellプレートに2×104 / well で播種し、10%牛胎児血清を添加したダルベッコ変法MEM培地(DMEM培地)で5日間培養した。培養5日目にDMEM培地で細胞を洗浄後、各濃度(0.00001重量%、0.0001重量%、0.001重量%)のクスノハガシワ抽出物又はコバテイシ抽出物を含むDMEM培地を加え、さらに培養を続けた。
ヒト毛乳頭細胞を12wellプレートに2×104 / well で播種し、10%牛胎児血清を添加したダルベッコ変法MEM培地(DMEM培地)で5日間培養した。培養5日目にDMEM培地で細胞を洗浄後、各濃度(0.00001重量%、0.0001重量%、0.001重量%)のクスノハガシワ抽出物又はコバテイシ抽出物を含むDMEM培地を加え、さらに培養を続けた。
C3H/Heマウス(8週齢、雄)の背部を剃毛し、1日に1回、0.1重量%のクスノハガシワ抽出物あるいはコバテイシ抽出物を含む50%エタノール溶液を0.1mlずつ、15日間塗布した。一方、抽出物を含まない50%エタノール溶液を、同様にC3H/Heマウスの背部に1日に1回塗布し、これを対照群とした。クスノハガシワ抽出物およびコバテイシ抽出物の毛成長促進効果は、剃毛後15日目における剃毛部の毛再生面積率を比較することにより調べた。その結果を表5に示す。
本処方例は、ヘアークリームの処方例であり、その組成は次のとおりである。
配合成分 重量%
精製ラノリン 4.0
流動パラフィン 40.0
モノステアリン酸ポリオキシエチレンソルビタン 4.0
モノステアリン酸ソルビタン 1.5
モノステアリン酸グリセリン 2.0
パラオキシ安息香酸メチル 0.1
セタノール 2.0
エデト酸四ナトリウム 0.1
クスノハガシワ抽出物 0.1
1,3−ブチレングリコール 4.0
ラウリル硫酸トリエタノールアミン 1.0
香料 0.1
精製水 残量
本処方例は、ヘアローションの処方例であり、その組成は次のとおりである。
配合成分 重量%
酢酸−dl−α−トコフェロール 0.05
グリチルリチン酸ジカリウム 0.1
l−メントール 0.1
クスノハガシワ抽出物 0.1
香料 0.1
パラオキシ安息香酸メチル 0.1
ジプロピレングリコール 3.0
エタノール 60.0
精製水 残量
本処方例は、ヘアローションの処方例であり、その組成は次のとおりである。
配合成分 重量%
酢酸−dl−α−トコフェロール 0.05
グリチルリチン酸ジカリウム 0.1
l−メントール 0.1
コバテイシ抽出物 0.1
香料 0.1
パラオキシ安息香酸メチル 0.1
ジプロピレングリコール 3.0
エタノール 60.0
精製水 残量
Claims (1)
- クスノハガシワ抽出物又はコバテイシ抽出物の少なくともいずれかを有効成分として含有することを特徴とする養毛剤。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004230808A JP3908245B2 (ja) | 2004-08-06 | 2004-08-06 | 養毛剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004230808A JP3908245B2 (ja) | 2004-08-06 | 2004-08-06 | 養毛剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006045157A true JP2006045157A (ja) | 2006-02-16 |
JP3908245B2 JP3908245B2 (ja) | 2007-04-25 |
Family
ID=36024153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004230808A Active JP3908245B2 (ja) | 2004-08-06 | 2004-08-06 | 養毛剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3908245B2 (ja) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010184916A (ja) * | 2009-02-13 | 2010-08-26 | Pias Arise Kk | 育毛剤 |
WO2010127396A1 (en) * | 2009-05-04 | 2010-11-11 | Cimtech Pty Limited | One or more of vigna marina, cocos nucifera l. or terminalia catappa l. extracts for treating wounds, skin disorders and hair loss |
JP2013203700A (ja) * | 2012-03-28 | 2013-10-07 | Mandom Corp | 体臭抑制剤 |
CN104161871A (zh) * | 2014-08-06 | 2014-11-26 | 张秀贞 | 白秃疮(白癣)外用搓涂酒剂及其制备方法 |
CN104161872A (zh) * | 2014-08-06 | 2014-11-26 | 张秀贞 | 斑秃外用搓涂酒剂及其制备方法 |
CN111474120A (zh) * | 2019-12-09 | 2020-07-31 | 北京理工大学 | 一种在细胞层面偏振成像的辅助性癌症诊断方法 |
-
2004
- 2004-08-06 JP JP2004230808A patent/JP3908245B2/ja active Active
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010184916A (ja) * | 2009-02-13 | 2010-08-26 | Pias Arise Kk | 育毛剤 |
WO2010127396A1 (en) * | 2009-05-04 | 2010-11-11 | Cimtech Pty Limited | One or more of vigna marina, cocos nucifera l. or terminalia catappa l. extracts for treating wounds, skin disorders and hair loss |
CN102458431A (zh) * | 2009-05-04 | 2012-05-16 | 库克岛医学技术有限公司 | 用于处理伤口、皮肤疾病和脱发的滨豇豆、椰子树或榄仁树提取物中的一种或多种 |
CN102458431B (zh) * | 2009-05-04 | 2016-02-17 | 库克岛医学技术有限公司 | 用于处理伤口、皮肤疾病和脱发的滨豇豆、椰子树或榄仁树提取物中的一种或多种 |
US9649512B2 (en) | 2009-05-04 | 2017-05-16 | Cimtech Pty Limited | One or more of Vigna marina, Cocos nucifera L. or Terminalia catappa L. extracts for treating wounds, skin disorders and hair loss |
JP2013203700A (ja) * | 2012-03-28 | 2013-10-07 | Mandom Corp | 体臭抑制剤 |
CN104161871A (zh) * | 2014-08-06 | 2014-11-26 | 张秀贞 | 白秃疮(白癣)外用搓涂酒剂及其制备方法 |
CN104161872A (zh) * | 2014-08-06 | 2014-11-26 | 张秀贞 | 斑秃外用搓涂酒剂及其制备方法 |
CN111474120A (zh) * | 2019-12-09 | 2020-07-31 | 北京理工大学 | 一种在细胞层面偏振成像的辅助性癌症诊断方法 |
CN111474120B (zh) * | 2019-12-09 | 2021-04-06 | 北京理工大学 | 未脱蜡-非染色切片上细胞的偏振成像检测方法 |
Also Published As
Publication number | Publication date |
---|---|
JP3908245B2 (ja) | 2007-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5663160A (en) | Cosmetic or dermatological composition containing at least one saponin of the ginsenoside type, and its applications, especially for treating the hair | |
CA2444282C (en) | Preparation for hair and/or scalp | |
JP3108586B2 (ja) | 育毛剤 | |
KR101196523B1 (ko) | 천연물 발효 추출물을 유효성분으로 하는 발모제 조성물 | |
JP4027949B2 (ja) | 養毛剤 | |
JP2008143784A (ja) | 細胞増殖促進剤 | |
KR102175249B1 (ko) | 인삼 추출물과 녹차 추출물을 함유하는 모발 또는 두피 상태 개선용 조성물 | |
JP2003176213A (ja) | 育毛剤 | |
KR102369387B1 (ko) | 탈모방지 및 발모촉진용 화장료 조성물 | |
KR102675966B1 (ko) | 탈모 방지 및 발모 촉진용 조성물 | |
JP2010184916A (ja) | 育毛剤 | |
JP3908245B2 (ja) | 養毛剤 | |
KR20140018666A (ko) | 발효콩 추출물을 함유하는 피부 외용제 조성물 | |
JP4460420B2 (ja) | コラーゲン生成促進剤 | |
JPH1160450A (ja) | 養毛剤 | |
JP7135106B2 (ja) | 頭皮頭髪用組成物 | |
JP2002284648A (ja) | 育毛剤組成物 | |
JP2010095496A (ja) | 毛成長サイトカインの産生調整剤、並びにそのサイトカインの産生調整剤を配合した育毛剤、医薬部外品、及び化粧料 | |
KR20210083236A (ko) | 탈모 방지 및 두피 개선용 조성물 | |
JP2002179584A (ja) | テストステロン5α−リダクターゼ阻害剤及びアンドロゲン受容体結合阻害剤、頭髪用剤並びに皮膚化粧料 | |
KR101177500B1 (ko) | 육모용 조성물 | |
JP3382148B2 (ja) | 頭部用外用剤 | |
JP5703340B2 (ja) | Hgfの産生促進剤 | |
JP4113518B2 (ja) | 体毛の毛成長抑制のためのTGF−β産生促進剤 | |
JP3542700B2 (ja) | 頭部用組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20060621 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060630 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060829 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070105 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070117 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 3908245 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110126 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120126 Year of fee payment: 5 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120126 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130126 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130126 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140126 Year of fee payment: 7 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |